M. Muller et al., CORRECTION OR TRANSFER OF IMMUNODEFICIENCY DUE TO TNF-LT-ALPHA DELETION BY BONE-MARROW TRANSPLANTATION, Molecular medicine, 2(2), 1996, pp. 247-255
Citations number
32
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Cell Biology
Background: Mice with inactivated tumor necrosis factor (TNF) and lymp
hotoxin alpha (LT alpha) genes have profound abnormalities of the immu
ne system including lymphocytosis, lack of lymph nodes, undifferentiat
ed spleen, hypoimmunoglobulinaemia, and defective Ig class switch. Her
e, we asked whether this phenotype is due to incompetent lymphohemopoi
etic progenitors or to a defective environment. Materials and Methods:
Lethally irradiated TNF-LT alpha-deficient and wild-type mice receive
d bone marrow cells from either TNF-LT alpha-deficient or wild-type mi
ce. The reconstitution and transfer of the phenotype was followed by m
orphological and functional analyses. Results: Bone marrow cells from
wild-type mice restored the synthesis of TNF and LT alpha, corrected t
he splenic microarchitecture, normalized the lymphocyte counts in the
circulation, and repopulated the lamina propria with IgA-producing pla
sma cells of TNF-LT alpha-deficient mice. Furthermore, the formation o
f germinal centers in the spleen and the defective Ig class switch in
response to a T-cell dependent antigen was corrected, while no lymph n
odes were formed. Conversely, the TNF-LT alpha phenotype could be tran
sferred to wild-type mice by bone marrow transplantation after lethal
irradiation. Conclusions: These data demonstrate that most TNF and LT
alpha-producing cells are bone marrow derived and radiosensitive, and
that the immunodeficiency due to TNF-LT alpha deletion can be correcte
d to a large extent by normal bone marrow cell transplantation The gen
otype of the donor bone marrow cells determines the functional and str
uctural phenotype of the TNF-LT alpha-deficient adult murine host, wit
h the exception of lymph node formation. These findings may have thera
peutic implications for the restoration of genetically defined immunod
eficiencies in humans.